Pittsburgh, PA (PRWEB) June 12, 2015 -- Lipella Pharmaceuticals Inc, today announced that Chief Medical Officer Michael Chancellor, MD will present at the 2015 BIO International Convention in Philadelphia, PA. The presentation will take place on Tuesday, June 16, at 10:45 a.m. (EST) in Theater 3 at the Pennsylvania Convention Center, 1101 Arch St.
Dr. Chancellor will provide an overview of Lipella’s current pipeline of drug candidates for indications in Interstitial Cystitis, Hemorrhagic Cystitis, and Overactive Bladder. For further company details visit http://www.lipella.com or Lipella’s exhibition space in the NIH Innovation Zone at the Bio International Convention, Booth 101.
About Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals is a biopharmaceutical company focused on the development of new drugs to treat patients with urinary bladder diseases and disorders. More infor-mation is available at http://www.lipella.com.
Lipella Pharmaceuticals Inc.
Source: Lipella Pharmaceuticals Inc.
David Chancellor, Lipella Pharmaceuticals, Inc., http://www.lipella.com, +1 412 894 1853, [email protected]
SOURCE Lipella Pharmaceuticals, Inc.